These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28645577)

  • 1. Quantitative structure-skin permeability relationships.
    Tsakovska I; Pajeva I; Al Sharif M; Alov P; Fioravanzo E; Kovarich S; Worth AP; Richarz AN; Yang C; Mostrag-Szlichtyng A; Cronin MTD
    Toxicology; 2017 Jul; 387():27-42. PubMed ID: 28645577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in predicting skin permeability of hydrophilic solutes.
    Chen L; Han L; Lian G
    Adv Drug Deliv Rev; 2013 Feb; 65(2):295-305. PubMed ID: 22580335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the skin permeation barrier: challenges and opportunities.
    Vitorino C; Sousa J; Pais A
    Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure.
    Dancik Y; Miller MA; Jaworska J; Kasting GB
    Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in skin mimic systems to predict transdermal permeation.
    Waters LJ
    Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement and prediction of the rate and extent of drug delivery into and through the skin.
    Russell LM; Guy RH
    Expert Opin Drug Deliv; 2009 Apr; 6(4):355-69. PubMed ID: 19382880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of mathematical models for predicting skin permeability.
    Lian G; Chen L; Han L
    J Pharm Sci; 2008 Jan; 97(1):584-98. PubMed ID: 17722002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting skin permeability from complex vehicles.
    Karadzovska D; Brooks JD; Monteiro-Riviere NA; Riviere JE
    Adv Drug Deliv Rev; 2013 Feb; 65(2):265-77. PubMed ID: 22342772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical models for dermal drug absorption.
    Selzer D; Neumann D; Schaefer UF
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1567-83. PubMed ID: 26166490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling and Prediction of Solvent Effect on Human Skin Permeability using Support Vector Regression and Random Forest.
    Baba H; Takahara J; Yamashita F; Hashida M
    Pharm Res; 2015 Nov; 32(11):3604-17. PubMed ID: 26033768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.
    Yamamoto S; Karashima M; Sano N; Fukushi C; Tohyama K; Arai Y; Hirabayashi H; Amano N
    Pharm Res; 2017 Nov; 34(11):2415-2424. PubMed ID: 28828717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-principles, structure-based transdermal transport model to evaluate lipid partition and diffusion coefficients of hydrophobic permeants solely from stratum corneum permeation experiments.
    Kushner J; Deen W; Blankschtein D; Langer R
    J Pharm Sci; 2007 Dec; 96(12):3236-51. PubMed ID: 17887175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid solubility and molecular weight: whose idea was that.
    Kasting GB
    Skin Pharmacol Physiol; 2013; 26(4-6):295-301. PubMed ID: 23921116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the effect of mixture components on permeation through skin.
    Ghafourian T; Samaras EG; Brooks JD; Riviere JE
    Int J Pharm; 2010 Oct; 398(1-2):28-32. PubMed ID: 20643197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
    J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and opportunities in dermal/transdermal delivery.
    Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
    Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysing the skin barrier from down under.
    Grice J; Benson HA
    Skin Pharmacol Physiol; 2013; 26(4-6):254-62. PubMed ID: 23921112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.